Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Satasairaala

Research site

Finland Sairaalantie 3, 28500 Pori, Finland

  • 2 trials recruiting
  • Atrial fibrillation · Cardiac sarcoidosis · Cerebrovascular accident
  • Adult patients

About Specializations

Satasairaala in Pori, Finland specialises in clinical trials of conditions such as Atrial fibrillation, Cardiac sarcoidosis, Cerebrovascular accident, Chronic kidney disease, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Research

The medical center is at the forefront of cardiovascular research, focusing on innovative approaches to prevent and manage heart-related conditions. A key area of study is the use of non-vitamin K oral anticoagulants (NOACs) for stroke prevention in patients experiencing perioperative atrial fibrillation following noncardiac surgery.

  • Stroke Prevention
  • Anticoagulation Therapy
  • Perioperative Care

Through rigorous clinical trials, the center aims to enhance patient outcomes by reducing the risk of non-hemorrhagic stroke and systemic embolism, while also addressing vascular mortality and other related complications.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Sairaalantie 328500 PoriFinland
Open in maps ↗
Recruiting now
2 trials
Conditions studied
7

More sites in PoriFinland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Atrial fibrillation+2

Recruiting

Study on Apixaban and Edoxaban for Preventing Stroke in Patients with Recent Perioperative Atrial Fibrillation After Noncardiac Surgery

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Hamilton Health Sciences Corporation

Atrial fibrillation+2

Recruiting

Study on Apixaban for Preventing Stroke in Patients with Atrial Fibrillation and Stage 5 Chronic Kidney Disease

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Karolinska University Hospital

Cardiac sarcoidosis+1

Not yet recruiting

Diagnostic PET Study of Al[18F]F-NOTA-folate in Patients with Suspected Cardiac Sarcoidosis or Infective Endocarditis

InvestigationalNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Sponsor:Turku University Hospital
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.